Choosing the first market for a skincare brand: rank markets by the room they leave your claim

Quality gets the product out. Culture gets the brand in. So in every new market a brand has to be incubated again — to that culture — not translated. A skincare brand entering its first overseas market settles four things in one move: the market, the compliance route that market imposes, the claim the brand may carry there, and the kind of factory that route requires. Terra Vista is a Japan-registered cross-border advisory group, and the page below sets out the order those four decisions run in, with the document behind every line so a ranking can be checked rather than taken on trust.

Growth rate does not decide the order. A market that cannot carry the sentence your category sells on does not become affordable by growing faster, and a market whose entry route your launch budget cannot finish is not an entry at all. Rank candidate markets by the room each one leaves your claim and by the route your budget can complete to the end, then let growth break the ties.

What a market report settles, and what it leaves open

A market research report states the size, the growth rate, the category structure and the competitive field of a defined market over a defined period, and none of the four outputs decides which market a skincare brand should enter first. Reports of that kind are published and purchasable. Absent from all of them is the thing actually being chosen: which route you can finish, and what you are allowed to say once you have finished it.

The three inputs that produce a ranking

A first-market ranking rests on three inputs a skincare brand already holds before any research is bought, and each of the three maps onto a different part of the entry route. The first input is what the product is for and how strong or mild its action on the body is, because that is the axis Japan’s Act uses to decide whether something counts as a cosmetic at all (Act No. 145 of 1960, Article 2(3)). Which category another candidate market would put the same product in is a question for that market’s own definition, since the Japanese provision settles Japan and says nothing either way about how anyone else draws the line.

Two of the three inputs sit in the launch plan rather than in the product itself. The second input is the launch budget, which decides which route you can carry to the end rather than to the middle. The third input is the date the first repeat order has to land, which decides how much unpublished duration you can absorb.

Running those three inputs against each candidate market produces answers under five headings, and the ordered list follows from all five rather than from any single one. Whether either market requires a responsible party inside the country is a sixth question, left open by the documents rather than answered by them, so it is carried further down among the blanks. Each answer below is a question about documents, not a question about market sentiment, and the five headings are these.

• Route feasibility, taken up as criterion one: which entry route the launch budget can complete gate by gate, rather than merely start.
• Duration, taken up as criterion two: how long the permission lasts once granted, and what has to be done to keep it alive.
• Claim room, taken up as criterion three: which market leaves the claim your category depends on intact, and which market removes it.
• Price of a wrong claim, taken up as criterion four: what each market charges when a sentence turns out to be one it does not allow.
• Carry-over, taken up as criterion five: how much of the first market’s paperwork the second market will accept.

An ordered list built from those five answers carries its own reasons, so the sequence can be argued with line by line instead of accepted as a whole. Japan and Thailand are worked through below because both have been checked against primary documents; Vietnam and other candidates belong in the same frame, and no rule of theirs is stated on this page.

Criterion one: whether the market gates the company or the product

Japan gates entry at the company by requiring a manufacture-and-distribution license for cosmetics before any import for sale, while Thailand gates entry at the product by requiring a notification receipt before any manufacture or import for sale. Two different objects are being permitted, and the difference lands on a launch budget and a launch calendar before it lands anywhere else.

Japan’s Act defines manufacture-and-distribution to include selling cosmetics that the seller has imported (Act No. 145 of 1960, Article 2(13)), which places an importing brand inside the licensed activity rather than beside it. Carrying on that business without the license is prohibited, and a breach carries up to three years’ imprisonment or a fine of up to 3,000,000 yen, or both (Articles 12(1) and 84(2)).

Products then move separately from the company. Ordinary cosmetics require a notification per item made in advance, and only cosmetics containing ingredients the Minister designates require item-by-item approval (Articles 14(1) and 14-9(1)). The provision imposes the obligation and states no processing time, so any duration quoted for that step comes from somewhere other than the statute.

A license holder importing cosmetics for sale must also hold, by the time of customs clearance, a document evidencing that the notification for that item has been made, an obligation the regulation places on the license holder rather than on importers generally (Enforcement Regulation, Article 94).

Thailand’s Cosmetic Act requires a person intending to manufacture for sale, import for sale, or manufacture under contract to notify the receiving officer, and the product may be manufactured or imported only once the receiving officer has issued the notification receipt (Cosmetic Act B.E. 2558, Section 14). Thai law calls that step notification rather than registration or approval, and the wording is not decorative: the two regimes run on different timetables and different costs.

One further condition sits on the Thai import route. An importer for sale must import product made by a manufacturer accredited to one of seven named manufacturing standards, or to a standard that is equivalent or not lower, and must obtain a letter of authorization from the trademark owner or the manufacturer (Ministry of Public Health notification of 2018, Annex B, clauses 4.1.1 and 4.1.2).

Named among the seven standards are International Organization for Standardization (ISO) 22716 and the Association of Southeast Asian Nations (ASEAN) Good Manufacturing Practice (GMP) guideline (Annex B, clause 4.1.1). English text of that notification is the authority’s own translation, whose footer states that the Thai original governs, so a factory shortlist should be confirmed against the Thai text before anything is committed.

Reading that table row by row shows the practical difference: Japan puts a company-level license in front of the first shipment, and Thailand puts a product-level receipt in front of it with a factory-standard condition attached. Each row carries the document it rests on, either in the cell itself or in the paragraphs immediately above the table, and no row rests on a summary of the others.

Criterion two: whether the permission expires, and what keeps it alive

Both Japan and Thailand attach a fixed term to the permission each market grants, and a skincare brand comparing routes should read that term from the instrument that actually sets the number rather than from the instrument that merely mentions a term. Renewal is where a first-market plan can break, and the two markets put the operative number in different places.

Japan’s Act states that the license lapses unless renewed at intervals fixed by Cabinet Order and not shorter than three years, and the Cabinet Order then fixes the interval at five years (Enforcement Order, Article 3). Reading the Act alone yields three years and a wrong renewal calendar. The operative number lives one document below the Act itself.

Operational detail sits lower still. The prefectural authority in Tokyo publishes a five-year term and asks for the renewal application two to three months before the term ends (Tokyo Metropolitan Institute of Public Health, after-licensing guidance). The standard processing period of twenty open days is published not in that guidance but on the same institute’s separate renewal-procedure page, where it is stated for renewal applications only (Tokyo Metropolitan Institute of Public Health, renewal procedure). No equivalent figure for a first-time application appears on either page.

Thailand writes the term into the Act itself: a notification receipt is valid for three years from the date of issue (Cosmetic Act B.E. 2558, Section 15). The Japanese pattern, where the statute sets a floor and a subordinate instrument sets the real number, does not repeat here, and carrying that assumption across the border produces the wrong date.

Renewal in Thailand runs on filing rather than on approval. A renewal application must be filed before the expiry date, and once the application is filed and the renewal fee paid, the receipt stays valid until the receiving officer orders that renewal be refused (Section 15, second paragraph). A receipt lapsed by not more than one month can still be taken to renewal with reasons and the fee, and that accommodation does not remove liability under the Act’s penalty provision.

No advance filing window expressed in days appears in that section (Section 15 as published). The third paragraph of the same section hands the criteria, the method and the conditions for renewal to a notification of the Minister of Public Health (Section 15, third paragraph), and that notification has not been read for this page.

So what a launch plan carries here is a question with an addressee rather than a number: put it to the Thai Food and Drug Administration (FDA), ask whether the notification made under that paragraph sets any advance filing window, and ask for the text of the notification rather than for a figure. No primary source stating such a window could be reached here, so until that text is in hand no day-count belongs in a renewal calendar.

Criterion three: how much room the market leaves the claim

The claim a skincare brand sells on has to survive in the market that brand enters first, and the two markets documented here draw the permitted line from opposite directions. Japan works from a closed list of what may be claimed; Thailand works from a list of what may not be said.

Japan’s efficacy range for cosmetics labelled and advertised without approval is the 56 items in the notice of 21 July 2011 (Yakushoku-hatsu 0721 No. 1, Appended Table 1). One of those items, making fine lines caused by dryness less noticeable, carries a condition the list does not show: the license holder must run a test under the Japanese Cosmetic Science Society anti-wrinkle evaluation guideline, or an appropriate test equivalent to it or more rigorous, confirm the effect, and retain the records (the same-day division-director notice, item 2(1)).

A second Japanese document closes the loop. The Standards for Fair Advertising of Drugs and Related Products cover every medium, naming newspapers, magazines, television, radio, websites and social networking services, and state that expressions of efficacy for cosmetics requiring no approval must not exceed the range set by the 2011 notice (Yakusei-hatsu 0929 No. 4, sections 2 and 4-3). Guarantees that an effect is certain, and superlative expressions of efficacy or safety, are prohibited by the same standards.

Testing may be outsourced while responsibility and record retention stay with the license holder, and nothing in that notice asks for submission to, or clearance by, the authorities. Outside the listed items, makeup effects and statements about how a product feels in use remain permissible so long as they are not contrary to fact (item 2(3) of the same notice).

The Japanese text of that notice ends the pair with the word 等, meaning “and the like”, so the efficacy list is closed while the carve-out beside it is not. Whether one further kind of sentence survives inside that carve-out is a question to put to the authority rather than one this page settles.

Thailand prohibits rather than permits. Cosmetic advertising must not use statements that are unfair to consumers or that may harm society as a whole, and the Act lists seven kinds, among them statements showing a therapeutic effect or an effect that is not a cosmetic purpose (Cosmetic Act B.E. 2558, Section 41). No positive list sits beside that section, so whether one particular sentence is allowed cannot be settled from the section alone.

Thailand also offers a route Japan’s documents do not describe. A notifier or an advertiser may ask the committee for an opinion before running an advertisement; the committee must give that opinion within sixty days of the office receiving the request; silence past the period counts as consent; and an act done in accordance with the opinion is not a criminal offence (Section 46). The section says may, not must, so anyone describing prior clearance as compulsory for Thai cosmetic advertising is describing something the Act does not say.

For a brand whose whole proposition is one efficacy sentence, claim room carries more weight in a ranking than any other criterion. A market that cannot carry the sentence removes the reason the brand is there, and no growth rate compensates for the removal.

Criterion four: what a wrong claim costs in each market

Each market prices a claim failure differently, and a brand ranking markets should read that price from the penalty provisions rather than from a marketing budget. Penalty structure also shows who is exposed, and the exposed party is not always the brand.

Japan’s prohibition on false or exaggerated advertising of efficacy is addressed to any person rather than only to the license holder, and a breach carries up to two years’ imprisonment or a fine of up to 2,000,000 yen, or both (Articles 66(1) and 85(4)). Agencies, distributors and anyone else who publishes the sentence fall inside that wording, although the provision itself draws no enforcement line.

A second and separate route runs alongside the criminal one. A surcharge is to be ordered at 4.5% of the total consideration for the products traded during the subject period, because the Act directs that payment be ordered rather than leaving the matter to discretion (Article 75-5-2(1)).

The subject period is capped at three years counted back from its last day, and no order issues where the computed amount falls below 2,250,000 yen (Article 75-5-2(2) and (4)). Where a business-suspension order is made in the same case, the Act allows the Minister not to order the surcharge, and does not state that the two cannot both follow (Article 75-5-2(3)). The base is consideration received, not profit, so a thin-margin launch does not shrink the figure.

Thailand’s advertising penalty is up to one year’s imprisonment or a fine of up to 100,000 baht, or both (Section 84), and quoting that ceiling alone understates the exposure. A separate section adds a daily fine of up to 10,000 baht where the offence is a continuing one, running for the whole period the party remains in violation or has not put the matter right (Section 88).

Two limits on that daily fine belong in the same breath. The Act does not define when a continuing offence begins or how correction is proved, and whether the daily fine is still criminal in character after Thailand’s later reform of fine-only offences is unresolved in the sources reachable so far. Any exposure figure built on those blanks would be our arithmetic rather than the law’s, so no such figure is published here.

Criterion five: what carries over to the second market

A first market earns a higher rank when the work that market forces reappears in the second market, and the reusable part is the file describing the product and the factory rather than the permission. Permissions are issued market by market, by the authority named in that market’s own provisions. The file, by contrast, describes objects that do not change when the border does.

The Association of Southeast Asian Nations (ASEAN) Cosmetic Directive sets the reusable core: the company or person responsible for placing a cosmetic on the market must keep specified information readily accessible to the regulator at the address shown on the label, covering composition, raw material and finished product specifications, the method of manufacture complying with good manufacturing practice, a safety assessment, existing data on undesirable effects, and supporting data for the benefits claimed (ASEAN Cosmetic Directive, Article 8).

No rule in that article counts files per product. A check of two independent copies of the directive found no occurrence of file, dossier, SKU, per product or each product anywhere in the text, and the Product Information File (PIF) guideline issued beside it opens by stating that it is not a legal document and that compliance is not a mandatory requirement (ASEAN guidelines for the Product Information File). Per-product file counts therefore have no source in either document.

Japan words one factory-side step as something to take up rather than something to satisfy. Accreditation of a foreign manufacturer that makes cosmetics for export to Japan is worded as something the manufacturer may receive, not must obtain (Article 13-3(1)). The provision does not state that accreditation is unnecessary and does not state that export without it is impossible, so the settled point is only that the route exists and reads as optional.

Ingredient answers do not carry over at all. Japan decides admissibility through the tables of its Cosmetic Standard, combining a prohibited list, maximum blending amounts, positive lists for preservatives and for ultraviolet absorbers, and a separate ordinance for tar colours (Notification No. 331 of 2000, Cosmetic Standard). Those tables are amended over time, so an individual ingredient question has to be put to the table text on the day it is asked.

Thailand moves on its own schedule. Ten subordinate instruments were published in the Government Gazette on 24 December 2025, adding 17 substances to the prohibited list in two tranches, 7 effective from 25 December 2025 and 10 from 22 June 2026, with both tranches now in force (Thai FDA clarification on the December 2025 batch). The document available is that clarification rather than the instruments themselves, so each substance identity has to come from the individual notification.

When the ranking should be rewritten

A ranking should be rewritten rather than defended when one of the conditions below turns up in a brand’s own inputs, and each of those conditions names the document it rests on. Ordering markets is a judgement, and a judgement has to survive contact with the constraints the brand actually has.

1. If the sentence your category sells on states an efficacy that is not among the 56 items listed in the 2011 notice, and is neither a makeup effect nor a statement about how the product feels in use, Japan cannot carry it as a cosmetic sold without approval: the advertising standards require expressions of efficacy for cosmetics requiring no approval not to exceed the range that notice sets (Yakusei-hatsu 0929 No. 4, section 4-3), and the same-day division-director notice keeps makeup effects and use-feel statements permissible outside it only so long as they are not contrary to fact, ending that pair with the word 等, meaning “and the like” (item 2(3) of that notice).
2. If the route that looks like it might fit instead is the quasi-drug route, treat it as a question to put rather than an assumption to make: the category reaches only what Article 2(2) lists and, in its third limb, only what the Minister designates, and it runs on approval item by item rather than notification (Articles 2(2) and 14(1)). What is at stake is therefore the claim itself or a heavier route, not merely time.
3. If the product carries an ingredient the Minister designates, Japan’s route changes from notification per item to approval per item, and the whole calendar changes with it (Article 14(1)).
4. If the factory cannot evidence accreditation to one of the seven accepted standards, or to a standard that is equivalent or not lower, the Thai import route stops at the door however attractive the market looks (Annex B, clause 4.1.1) — a condition read here in the authority’s own English rendering of the 2018 notification, whose footer gives the Thai original the governing text, so a shortlist should be confirmed against the Thai text before anything is committed.
5. If the first repeat order has to land within a few months, weigh Japan’s company-level license carefully, since the license sits ahead of the first shipment and no first-time processing period appears on either of the two Tokyo pages read here: the standard period of twenty open days is stated for renewal applications (Tokyo renewal page), and the after-licensing guidance gives the five-year term and the filing window instead (Tokyo after-licensing guidance).
6. If the budget was built on the fee figures printed in the Thai schedule, rebuild it, because those figures are statutory ceilings rather than prices (Section 5 and the schedule of fees).

Each condition above changes the order for a stated reason, so a revised ranking can be checked against the same documents as the original one. Conditions that cannot be sourced do not go on the list. A ranking that moves for an unstated reason is not a ranking at all, only a preference wearing the shape of one.

What the documents do not settle

Four questions that move a first-market ranking are not settled by any primary source reachable so far, and naming the four openly belongs in the deliverable rather than in a footnote. A ranking that hides its blanks cannot be checked, and a hidden blank turns into a schedule slip later. Nothing on this page is legal advice.

Whether a brand outside Japan can hold the Japanese license without a local base is the first blank. Japan’s Cabinet Order fixes jurisdiction by the location of the office where the marketing supervisor-general performs those duties, and requires nowhere that the applicant be a Japanese corporation (Enforcement Order, Article 80(2)). The qualification rule for that supervisor-general offers four alternatives, beginning with being a pharmacist, and states nothing about residence, full-time employment or exclusivity (Enforcement Regulation, Article 85-2(2)).

Neither provision answers the question either way, so the question is carried as an item to put to the regulator instead of being read as permission. Nothing in either provision says the applicant may proceed without a local base, and reading that silence as permission puts a launch date on something no document supports.

Whether a Thai notifier must be established in Thailand is the second blank. Thailand’s notification section names three roles, being manufacturer for sale, importer for sale and contract manufacturer, and states no establishment requirement (Section 14). The labelling section requires the importer’s name and location on the pack (Section 22), which points toward a local point of presence without requiring one, and pointing toward is not converted into a rule here.

Actual Thai fees are the third blank. The Act empowers the Minister to prescribe fees by ministerial regulation not exceeding the rates in the schedule, which makes the schedule’s 5,000 baht for an import notification receipt a ceiling rather than a price (Section 5 and the schedule of fees). The ministerial regulation that sets the operative figure has not been read, so a budget line quoting the schedule is quoting the wrong number.

Processing time for a first Japanese application is the fourth blank, and the only standard processing period Tokyo publishes covers renewal applications (Tokyo renewal page). A duration neither Tokyo page states still sits on the critical path, which argues for starting that step early rather than for assuming the step is short. Whether any other prefecture publishes a first-time figure is a question for that prefecture’s own pages, which were not read here.

The order, and why it runs this way

The break in cross-border business is not logistics — it is culture. Goods ship, money moves, regulations can be checked. What cannot be shipped is business context, decision logic, and how trust is built. Choosing a first market is the first place that shows, because the market decides the compliance route, the route decides the claim, and the claim decides the kind of factory the brand needs.

So the way we work is: Culture as the bridge, understanding as the path. Across the four steps that means Culture Isn’t Cargo — understand culture, don’t just ship it: not translating the proposition that already worked at home and posting it into a new market, but first working out how buyers there judge and how they come to trust, and only then deciding what gets said and what gets built first.

Choose the market, then work out that market’s rules, then write the claim, and choose the factory last. That order is laid out step by step on our brand incubation studio page, and the step after this one works out which rules actually bind the product whose market you have just chosen.

Three kinds of supplier already sit around a first-market decision, and each owns one segment: the factory answers for what the line can make, the regulatory adviser for what the statute says, the agency for how the campaign runs. What we own is the brand not changing shape as it moves between them. Terra Vista is a Japan-registered cross-border advisory group, and every regulatory line above is handed over with the document it rests on and the point at which that document stops.

Questions this step answers

Which market should I enter first?

The market that leaves room for the claim your category depends on, and whose entry route your launch budget can carry to the end, should be ranked first. Growth rate breaks ties between markets that both pass those two tests, rather than deciding the order on its own.

The report says one market is growing fastest, so why not follow that?

Growth describes demand that already exists, while the entry route describes what has to be built before any of that demand can be sold to. Two different sets of documents decide the two, and only the second set can stop a launch outright.

Under what conditions should the order change?

Order changes when a market removes the claim the brand depends on, when the product form moves the brand into a heavier approval track, when the factory cannot evidence the standard the market requires, or when a required step has a duration no published source states.

How much of the first market’s work carries over to the second?

Documents describing the product and the factory tend to be reusable, because different markets ask about the same underlying objects. Permission itself is not reusable, since each market grants its own through the authority named in its own provisions and on its own term.